Literature DB >> 17112561

Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation.

Patricia Devaux1, Veronika von Messling, Warangkhana Songsungthong, Christoph Springfeld, Roberto Cattaneo.   

Abstract

The measles virus (MV) P gene encodes three proteins: P, an essential polymerase cofactor, and C and V, which have multiple functions including immune evasion. We show here that the MV P protein also contributes to immune evasion, and that tyrosine 110 is required to block nuclear translocation of the signal transducer and activator of transcription factors (STAT) after interferon type I treatment. In particular, MV P inhibits STAT1 phosphorylation. This is shown not only by transient expression but also by reverse genetic analyses based on a new functional infectious cDNA derived from a MV vaccine vial (Moraten strain). Our study also identifies a conserved sequence around P protein tyrosine 110 as a candidate interaction site with a cellular protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112561     DOI: 10.1016/j.virol.2006.09.049

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  100 in total

1.  Measles virus C protein interferes with Beta interferon transcription in the nucleus.

Authors:  Konstantin M J Sparrer; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity.

Authors:  Kerstin M Schuhmann; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Membrane fusion-mediated autophagy induction enhances morbillivirus cell-to-cell spread.

Authors:  Sébastien Delpeut; Penny A Rudd; Patrick Labonté; Veronika von Messling
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

4.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

5.  Full genome sequence of a peste des petits ruminants virus (PPRV) from Ghana.

Authors:  W G Dundon; C Adombi; A Waqas; H R Otsyina; C T Arthur; R Silber; A Loitsch; A Diallo
Journal:  Virus Genes       Date:  2014-08-24       Impact factor: 2.332

6.  Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Neelam Dhiman; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  J Med Virol       Date:  2010-11       Impact factor: 2.327

7.  3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation.

Authors:  Yijun Du; Jingshan Bi; Jiyu Liu; Xing Liu; Xiangju Wu; Ping Jiang; Dongwan Yoo; Yongguang Zhang; Jiaqiang Wu; Renzhong Wan; Xiaomin Zhao; Lihui Guo; Wenbo Sun; Xiaoyan Cong; Lei Chen; Jinbao Wang
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed.

Authors:  Vincent H J Leonard; Patrick L Sinn; Gregory Hodge; Tanner Miest; Patricia Devaux; Numan Oezguen; Werner Braun; Paul B McCray; Michael B McChesney; Roberto Cattaneo
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

9.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.